FindTrial
Sign In

Expanded Access for Iberdomide

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT07434960
Enrollment
Unknown
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an expanded access designed to provide access to Iberdomide for eligible participants.

Interventions

DRUGIberdomide

Sponsors

Bristol-Myers Squibb
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

CONTACTBMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Clinical.Trials@bms.com855-907-3286
CONTACTFirst line of the email MUST contain the NCT# and Site #.
STUDY_DIRECTORBristol-Myers Squibb

Bristol-Myers Squibb

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026